<DOC>
	<DOCNO>NCT02727621</DOCNO>
	<brief_summary>Dexmedetomidine unique sedative anesthetic agent allow accurate control depth sedation provide analgesia , cardio protection , renal protection , neuroprotection without cause respiratory depression . It alpha 2-adrenoreceptor agonist modulates release catecholamines central autonomic nervous system . When patient sedate dexmedetomidine allow become responsive , calm cooperative ( 1 ) . No sedative agent feature , sedate patient frequently awaken confused state . Investigators conduct study project compare dexmedetomidine base propofol base anesthetic technique regard hemodynamic change , stress hormone release well cytokines patient undergo CPB coronary revascularization .</brief_summary>
	<brief_title>Dexmedetomidine Sedation Cardiopulmonary Bypass</brief_title>
	<detailed_description>100 patient undergoing elective CPB coronary revascularization surgery . On morning operation patient randomize receive one two anesthetic technique dependent type sedation use . Standard anesthetic technique use patient except use dexmedetomidine sedation one group propofol sedation group .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>patient schedule elective coronary revascularization surgery cardiopulmonary bypass Severely impaired leave ventricular function ( ejection fraction &lt; 40 % ) Valvular heart disease Low cardiac output syndrome Uncontrolled rapid atrial fibrillation On plavix le one week Severe systemic noncardiac disease Infectious disease Poorly control diabetes mellitus patient corticosteroids immunosuppressive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Cardiac</keyword>
	<keyword>Coronary Artery Bypass Grapht</keyword>
	<keyword>Sedation</keyword>
	<keyword>Propofol</keyword>
	<keyword>Intravenous Anesthetics</keyword>
</DOC>